Pharma manufacturing news in brief
November 9, 2011Manufacturing and Production manufacturing and production news
Nephron earmarks $313m for new US facility, police break up a demonstration at Dr Reddy’s with tear gas, plus updates …
‘Military-inspired’ project wins 2011 Facility of the Year Award
November 9, 2011Manufacturing and Production MedImmune, manufacturing and production
MedImmune’s US manufacturing plant in Frederick, Maryland, has won the 2011 Facility of the Year Award, beating out rival category …
Edge Medical Communications makes two senior appointments
November 9, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Edge Medical, Medical comms
Edge Medical Communications has appointed Dr Laurence De-Netto as account director and Dr Elizabeth Rapley as business development manager. Dr …
Amylin to pay up to $1.6 billion to sever ties with Lilly
November 8, 2011Research and Development, Sales and Marketing Amylin, Bydureon, Byetta, R&D, lilly
Amylin will pay up to $1.6 billion to end its diabetes pact with Lilly after a difficult year for the …
Strategic alliance executives
November 8, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CTPartners, Strategic alliance executives
Given the extraordinary costs and risks associated with drug discovery and development, it’s not surprising that an increasing number of …
AZ and Targacept’s novel depression drug misses target
November 8, 2011Research and Development, Sales and Marketing AstraZeneca
AstraZeneca and Targacept’s next generation depression drug has failed to meet its primary endpoint in a late-stage trial. The first …
UK pharma downbeat on its future – survey
November 8, 2011Research and Development ABPI, R&D, VBP, rsa
The impacts of NHS reform and the increasingly high cost of R&D is causing pharma to doubt its future in …
Organising a successful event
November 8, 2011Sales and Marketing
Company conferences and events have come a long way since we used to be taken out for a short meeting …
Market access – looking back
November 8, 2011Sales and Marketing
Market access is complicated. Multifaceted, multi-discipline, multidimensional, multi-stake-holder, all these multiples make Market Access one of the most challenging and …
Daniel Grau appointed as president of Heptares
November 8, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Daniel Grau, Heptares
Daniel Grau has been appointed as president of Heptares Therapeutics, a specialist in G-protein-coupled receptors. Mr Grau has been a …
Pfizer to retain an extra 300 jobs at Sandwich site
November 8, 2011Manufacturing and Production, Research and Development Jobs, Pfizer, Sandwich
Pfizer will now keep up to 650 jobs at its R&D site in Sandwich, Kent, according to news reports. The …
TranslatePharma now partnered with European Regulatory Solutions
November 8, 2011As a part of the ERA Consultancy Group, European Regulatory Solutions (ERS) specialise in offering consultancy services and regulatory advice …
GSK taps Alnylam tech for vaccine production
November 7, 2011Manufacturing and Production, Sales and Marketing Alnylam, GSK, vaccines
GlaxoSmithKline has teamed up with gene silencing specialist Alnylam Pharmaceuticals in a project aimed at speeding up the production of …
Bosch planning second packaging plant in China
November 7, 2011Manufacturing and Production Bosch, China
Bosch Packaging Technology has decided to boost its presence in Asia with the construction of a second plant in the …
Contract research news in brief
November 7, 2011Manufacturing and Production
No new suitors come forward for PPD, Icon and Charles River report mixed Q3 results, plus updates from Cyprotex and …
Ex-Pfizer R&D head Dr David Roblin joins Destiny Pharma
November 7, 2011Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Destiny Pharma, Pfizer, R&D
Anti-microbial drug developers Destiny Pharma have appointed Dr David Roblin as its new medical director. Dr Roblin was formerly head …
Aslan licences promising cancer drug from Bristol-Myers Squibb
November 7, 2011Research and Development, Sales and Marketing Aslan, BMS, Cancer
Bristol-Myers Squibb has licensed one of its investigational oncology compounds, for the treatment of multiple solid tumours, to Singapore-based Aslan …
Xarelto gains lucrative new licence from FDA
November 7, 2011Sales and Marketing
The FDA has approved Bayer/J&J’s Xarelto once-daily pill for stroke prevention in patients with an abnormal heart rhythm. The US …
Ranbaxy to collaborate with Teva on generic Lipitor in US?
November 7, 2011Manufacturing and Production, Sales and Marketing Lipitor, Pfizer, Ranbaxy, Teva
Israeli drugmaker Teva Pharmaceutical could get an unexpected boost from an earlier-than-expected launch of its generic version of Pfizer’s cholesterol …
Steve Hobbs joins Apodi senior management team
November 4, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Steve Hobbs has joined Apodi’s senior management team as director of business and account development. Steve has over 30 years …
Latest content
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
